Major depression (MD) is one of the most prevalent psychiatric disorders and a leading
cause of loss in work productivity. A combination of genetic and environmental risk factors …

Major depressive disorder (MDD) is associated with abnormal neural circuitry. It can be
measured by assessing functional connectivity (FC) at resting-state functional MRI, that may help …

Context Indirect evidence suggests that the glycogen synthase kinase-3β (GSK3β) gene
might be implicated in major depressive disorder (MDD). Background We evaluated …

The hippocampus consists of anatomically and functionally distinct subfields that may be
differentially involved in the pathophysiology of bipolar disorder (BD). Here we, the Enhancing …

Recent evidence suggests that hippocampal changes are present in vascular cognitive
impairment but their importance and relationship with ischaemic mechanisms remain …

Several lines of evidence implicate glycogen synthase kinase 3 beta (GSK3β) in mood disorders.
We recently reported associations between GSK3β polymorphisms and brain structural …

BACKGROUND AND PURPOSE Major depressive disorder (MDD) presents with extensive
clinical heterogeneity. In particular, overlap with anxiety symptoms is common during …

Depression is a debilitating disorder with high prevalence and socioeconomic cost, but the
brain-physiological processes that are altered during depressive states are not well …

Measurement of brain atrophy has been proposed as a surrogate marker in MS and
degenerative dementias. Although cerebral small vessel disease predominantly affects white and …

Replications of the association between APOE-ε4 allele load and regional brain atrophy in
Alzheimer's disease (AD) patients hold promise for future studies testing relationships …